{
  "bill_id": "OR2025000H3613",
  "source_url": "http://custom.statenet.com/public/resources.cgi?id=ID:bill:OR2025000H3613&cuiq=93d84396-c63b-526a-b152-38b7f79b4cfd&client_md=e4f6fea4-27b4-5d41-b7d3-766fe52569f0",
  "versions": [
    {
      "date": "02/18/2025",
      "label": "Introduced",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:OR2025000H3613&verid=OR2025000H3613_20250218_0_I&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 OR H 3613</td> <td><table><tr><td class=\"label\">Author:</td> <td>Nelson</td></tr> <tr><td class=\"label\">Version:</td> <td>Introduced</td></tr> <tr><td class=\"label\">Version Date:</td> <td>02/18/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session</p>\n   <p class=\"center\">\n    <b>House Bill 3613</b>\n   </p>\n   <p class=\"left\">Sponsored by Representative NELSON</p>\n   <p class=\"center\">\n    <b>SUMMARY</b>\n   </p>\n  </div>\n  <a name=\"digest_document_section\"></a><div class=\"digest\">\n   <p class=\"indent\">The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject to consideration by the Legislative Assembly. It is an editor&rsquo;s brief statement of the essential features of the measure as introduced. The statement includes a measure digest written in compliance with applicable readability standards.</p>\n   <p class=\"indent\">Digest: Creates the OPP and moves the OPDP to OPP. Makes some changes to OPDP and PMPDP. Takes effect 91 days after session ends. (Flesch Readability Score: 88.4).</p>\n   <p class=\"indent\">Creates the Office of Pharmaceutical Purchasing within the Oregon Department of Administrative Services to support multiagency and multistate collaborative purchasing of pharmaceuticals, drive down the cost of prescription drugs for residents of this state and manage the Oregon Prescription Drug Program.</p>\n   <p class=\"indent\">Creates an advisory board within the Office of Pharmaceutical Purchasing to assist in coordinating pharmaceutical purchasing across state agencies and programs.</p>\n   <p class=\"indent\">Transfers the Oregon Prescription Drug Program from the Oregon Health Authority to the Office of Pharmaceutical Purchasing and modifies the program, including by requiring certain agencies and coordinated care organizations to participate.</p>\n   <p class=\"indent\">Clarifies that a uniform Practitioner-Managed Prescription Drug Plan and preferred drug list should be used in both fee-for-service reimbursements and prescription drugs provided by coordinated care organizations.</p>\n   <p class=\"indent\">Takes effect on the 91st day following adjournment sine die.</p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"center\">\n    <b>A BILL FOR AN ACT</b>\n   </p>\n   <p class=\"left\">Relating to pharmaceutical purchasing; creating new provisions; amending ORS 410.080, 413.011, 413.032, 414.312, 414.314, 414.318, 414.320, 414.334 and 414.359; and prescribing an effective date.</p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"left\">\n     <b>Be It Enacted by the People of the State of Oregon:</b>\n    </p>\n   </span>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 1.</u>\n    </b>\n    <u class=\"amendmentInsertedText\">Sections 2 to 4 of this 2025 Act are added to and made a part of ORS chapter 414.</u>\n   </p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 2.</u>\n    </b>\n    <u class=\"amendmentInsertedText\">(1) The Office of Pharmaceutical Purchasing is established in the Oregon Department of Administrative Services to support multiagency and multistate collaborative purchasing of pharmaceuticals and drive down the cost of prescription drugs for residents of this state.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) The purpose of the office is to:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(a) Improve coordination in pharmaceutical purchasing to reduce costs for taxpayers and consumers;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) Leverage the state&rsquo;s collective purchasing power to promote cost savings, efficiency and transparency while maintaining excellent service of each purchasing entity;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) Enhance the Oregon Prescription Drug Program and integrate uniform standards across this state&rsquo;s medical assistance program that will further reduce administrative burden and optimize resource utilization;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(d) Establish and administer a multistate prescription drug purchasing consortium; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(e) Administer all intergovernmental and interagency agreements necessary to achieve the office&rsquo;s purposes described in this subsection.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(3) The office shall:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(a) Provide oversight for all state pharmaceutical purchasing and state contracts related to pharmaceutical procurement and payments;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) Administer the Oregon Prescription Drug Program;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) Develop and enforce rules for statewide purchasing agreements, payments made to pharmacies and procurement standards;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(d) Monitor state pharmaceutical purchasing by examining the data collected and maintained by state agencies related to pharmaceutical purchases;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(e) Coordinate and facilitate the work of the advisory board established in section 3 of this 2025 Act; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(f) No later than October 1 of each year, submit a report to the Legislative Assembly in the manner provided in ORS 192.245, after consultation from the advisory board, that includes at a minimum:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(i) Total pharmaceutical expenditures by agency and program;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(ii) Identification of fragmentation in state pharmaceutical purchasing;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(iii) Current procurement practices of each agency and program;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(iv) Barriers to effective defragmentation and leveraging of purchasing power; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(v) Recommendations for legislative action to reduce costs and improve coordination.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(4) The Director of the Department of Administrative Services shall appoint an administrator for the office and all subordinate officers and employees of the office.</u>\n   </p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 3.</u>\n    </b>\n    <u class=\"amendmentInsertedText\">(1) There is created in the Office of Pharmaceutical Purchasing the Office of Pharmaceutical Purchasing Advisory Board. The purpose of the advisory board is to coordinate pharmaceutical purchasing across state agencies and programs.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) The administrator of the Office of Pharmaceutical Purchasing shall serve as chair of the advisory board and, after consultation with the Governor, shall appoint the following members:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(a) The executive director of the Oregon Educators Benefit Board;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) The executive director of the Public Employees&rsquo; Benefit Board;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) The executive director of the Public Employees Retirement System;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(d) The executive director of the Prescription Drug Affordability Board; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(e) A member representing each of the following entities:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(A) The Department of Corrections;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(B) The Oregon State Hospital;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(C) The Oregon Health Authority pharmacy policy and programs office;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(D) Local health departments;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(E) The Universal Health Plan Governance Board;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(F) Oregon State University College of Pharmacy; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(G) An Oregon Health Authority public health representative.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(3) With approval from a majority of the advisory board members, the administrator may appoint additional members to the advisory board.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(4) One less than a majority of the advisory board constitutes a quorum for the transaction of business.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(5) The advisory board shall be considered a public body and is subject to ORS 192.610 to 192.705.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(6) The advisory board shall:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(a) Meet at least once per quarter;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) Review the recommendations made by the Office of Pharmaceutical Purchasing regarding defragmentation;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) Communicate to the office the barriers and challenges that inhibit effective leveraging of pharmaceutical purchasing power;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(d) Develop legislative recommendations to reduce fragmentation and improve Oregon&rsquo;s pharmaceutical purchasing power;</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(e) Review the multistate purchasing consortium growth and savings reports and advise the administrator of the office; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(f) Serve as stewards of Oregon tax dollars to ensure that every agency and program maintains service excellence while effectively leveraging Oregon&rsquo;s collective pharmaceutical purchasing power.</u>\n   </p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 4.</u>\n    </b>\n    <u class=\"amendmentInsertedText\">The Office of Pharmaceutical Purchasing shall adopt rules to carry out the provisions of sections 2 and 3 of this 2025 Act.</u>\n   </p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 5.</u>\n    </b> ORS 414.312 is amended to read:</p>\n   <p class=\"indent\">414.312. (1) As used in ORS 414.312 to 414.318:</p>\n   <p class=\"indent\">(a) &ldquo;Pharmacy benefit manager&rdquo; means an entity that negotiates and executes contracts with pharmacies, manages preferred drug lists, negotiates rebates with prescription drug manufacturers and serves as an intermediary between the Oregon Prescription Drug Program, prescription drug manufacturers and pharmacies.</p>\n   <p class=\"indent\">(b) &ldquo;Prescription drug claims processor&rdquo; means an entity that processes and pays prescription drug claims, adjudicates pharmacy claims, transmits prescription drug prices and claims data between pharmacies and the Oregon Prescription Drug Program and processes related payments to pharmacies.</p>\n   <p class=\"indent\">(c) &ldquo;Program price&rdquo; means the reimbursement rates and prescription drug prices established by the administrator of the Oregon Prescription Drug Program.</p>\n   <p class=\"indent\">(2) The Oregon Prescription Drug Program is established in the <strike class=\"amendmentDeletedText\">Oregon Health Authority</strike>\n    <u class=\"amendmentInsertedText\">Office of Pharmaceutical Purchasing</u> . The purpose of the program is to:</p>\n   <p class=\"indent\">(a) Purchase prescription drugs, replenish prescription drugs dispensed or reimburse pharmacies for prescription drugs in order to receive discounted prices and rebates;</p>\n   <p class=\"indent\">(b) Make prescription drugs available at the lowest possible cost to participants in the program as a means to promote health;</p>\n   <p class=\"indent\">(c) Maintain a list of prescription drugs recommended as the most effective prescription drugs available at the best possible prices; and</p>\n   <p class=\"indent\">(d) Promote health through the purchase and provision of discount prescription drugs and coordination of comprehensive prescription benefit services for eligible entities and members.</p>\n   <p class=\"indent\">(3) The <strike class=\"amendmentDeletedText\">Director of the Oregon Health Authority</strike>\n    <u class=\"amendmentInsertedText\">administrator of the office</u> shall appoint an administrator of the Oregon Prescription Drug Program. The administrator may:</p>\n   <p class=\"indent\">(a) Negotiate price discounts and rebates on prescription drugs with prescription drug manufacturers or group purchasing organizations;</p>\n   <p class=\"indent\">(b) Purchase prescription drugs on behalf of individuals and entities that participate in the program;</p>\n   <p class=\"indent\">(c) Contract with a prescription drug claims processor to adjudicate pharmacy claims and transmit program prices to pharmacies;</p>\n   <p class=\"indent\">(d) Determine program prices and reimburse or replenish pharmacies for prescription drugs dispensed or transferred;</p>\n   <p class=\"indent\">(e) Adopt and implement a preferred drug list for the program;</p>\n   <p class=\"indent\">(f) Develop a system for allocating and distributing the operational costs of the program and any rebates obtained to participants of the program; and</p>\n   <p class=\"indent\">(g) Cooperate with other states or regional consortia in the bulk purchase of prescription drugs.</p>\n   <p class=\"indent\">(4) The following individuals or entities may participate in the program:</p>\n   <p class=\"indent\">(a) Public Employees&rsquo; Benefit Board, Oregon Educators Benefit Board and Public Employees Retirement System;</p>\n   <p class=\"indent\">(b) Local governments as defined in ORS 174.116 and special government bodies as defined in ORS 174.117 that directly or indirectly purchase prescription drugs;</p>\n   <p class=\"indent\">(c) Oregon Health and Science University established under ORS 353.020;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(d) State agencies that directly or indirectly purchase prescription drugs, including agencies that dispense prescription drugs directly to persons in state-operated facilities;</strike>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(e)</strike>\n    <u class=\"amendmentInsertedText\">(d)</u> Residents of this state who lack or are underinsured for prescription drug coverage;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(f)</strike>\n    <u class=\"amendmentInsertedText\">(e)</u> Private entities; and</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(g)</strike>\n    <u class=\"amendmentInsertedText\">(f)</u> Labor organizations.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(5) The following individuals or entities must participate in the program unless the individual or entity can demonstrate that a lower price is available for the same prescription drug without utilizing the program:</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(a) State agencies that directly or indirectly purchase prescription drugs, including agencies that dispense prescription drugs directly to persons in state-operated facilities; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) Coordinated care organizations.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(5)</strike>\n    <u class=\"amendmentInsertedText\">(6)</u> The administrator may establish different program prices for pharmacies in rural areas to maintain statewide access to the program.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(6)</strike>\n    <u class=\"amendmentInsertedText\">(7)</u> The administrator may establish the terms and conditions for a pharmacy to enroll in the program. A licensed pharmacy that is willing to accept the terms and conditions established by the administrator may apply to enroll in the program.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(7)</strike>\n    <u class=\"amendmentInsertedText\">(8)</u> Except as provided in subsection <strike class=\"amendmentDeletedText\">(8)</strike>\n    <u class=\"amendmentInsertedText\">(9)</u> of this section, the administrator may not:</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(a) Contract with a pharmacy benefit manager;</strike>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(b)</strike>\n    <u class=\"amendmentInsertedText\">(a)</u> Establish a state-managed wholesale or retail drug distribution or dispensing system; or</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(b)</u> Require pharmacies to maintain or allocate separate inventories for prescription drugs dispensed through the program.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(8)</strike>\n    <u class=\"amendmentInsertedText\">(9)</u> The administrator shall contract with one or more entities to perform any of the functions of the program, including but not limited to:</p>\n   <p class=\"indent\">(a) Contracting with a pharmacy benefit manager and directly or indirectly with such pharmacy networks as the administrator considers necessary to maintain statewide access to the program.</p>\n   <p class=\"indent\">(b) Negotiating with prescription drug manufacturers on behalf of the administrator.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(9)</strike>\n    <u class=\"amendmentInsertedText\">(10)</u> Notwithstanding subsection <strike class=\"amendmentDeletedText\">(4)(e)</strike>\n    <u class=\"amendmentInsertedText\">(4)(d)</u> of this section, individuals who are eligible for Medicare Part D prescription drug coverage may participate in the program.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(10)</strike>\n    <u class=\"amendmentInsertedText\">(11)</u> The program may contract with vendors as necessary to utilize discount purchasing programs, including but not limited to group purchasing organizations established to meet the criteria of the Nonprofit Institutions Act, 15 U.S.C. 13c, or that are exempt under the Robinson-Patman Act, 15 U.S.C. 13.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 6.</u>\n    </b> ORS 414.314 is amended to read:</p>\n   <p class=\"indent\">414.314. (1) An individual or entity described in ORS 414.312 (4) may apply to participate in the Oregon Prescription Drug Program. Participants shall apply on an application provided by the <strike class=\"amendmentDeletedText\">Oregon Health Authority</strike>\n    <u class=\"amendmentInsertedText\">Office of Pharmaceutical Purchasing</u> . The <strike class=\"amendmentDeletedText\">authority</strike>\n    <u class=\"amendmentInsertedText\">office</u> may charge participants a nominal fee to participate in the program. The <strike class=\"amendmentDeletedText\">authority</strike>\n    <u class=\"amendmentInsertedText\">office</u> shall issue a prescription drug identification card to participants of the program.</p>\n   <p class=\"indent\">(2) The <strike class=\"amendmentDeletedText\">authority</strike>\n    <u class=\"amendmentInsertedText\">office</u> shall provide a mechanism to calculate and transmit the program prices for prescription drugs to a pharmacy. The pharmacy shall charge the participant the program price for a prescription drug.</p>\n   <p class=\"indent\">(3) A pharmacy may charge the participant the professional dispensing fee set by the <u class=\"amendmentInsertedText\">Oregon Health</u> Authority.</p>\n   <p class=\"indent\">(4) Prescription drug identification cards issued under this section must contain the information necessary for proper claims adjudication or transmission of price data.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 7.</u>\n    </b> ORS 414.318 is amended to read:</p>\n   <p class=\"indent\">414.318. The Prescription Drug Purchasing Fund is established separate and distinct from the General Fund. The Prescription Drug Purchasing Fund shall consist of moneys appropriated to the fund by the Legislative Assembly and moneys received by the <strike class=\"amendmentDeletedText\">Oregon Health Authority</strike>\n    <u class=\"amendmentInsertedText\">Oregon Department of Administrative Services</u> for the purposes established in this section in the form of gifts, grants, bequests, endowments or donations. The moneys in the Prescription Drug Purchasing Fund are continuously appropriated to the <strike class=\"amendmentDeletedText\">authority</strike>\n    <u class=\"amendmentInsertedText\">department</u> and shall be used to purchase prescription drugs, reimburse pharmacies for prescription drugs and reimburse the <strike class=\"amendmentDeletedText\">authority</strike>\n    <u class=\"amendmentInsertedText\">department</u> for the costs of administering the Oregon Prescription Drug Program, including contracted services costs, computer costs, professional dispensing fees paid to retail pharmacies and other reasonable program costs. Interest earned on the fund shall be credited to the fund.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 8.</u>\n    </b> ORS 414.320 is amended to read:</p>\n   <p class=\"indent\">414.320. The <strike class=\"amendmentDeletedText\">Oregon Health Authority</strike>\n    <u class=\"amendmentInsertedText\">Office of Pharmaceutical Purchasing</u> shall adopt rules to implement and administer ORS 414.312 to 414.318. The rules shall include but are not limited to establishing procedures for:</p>\n   <p class=\"indent\">(1) Issuing prescription drug identification cards to individuals and entities that participate in the Oregon Prescription Drug Program; and</p>\n   <p class=\"indent\">(2) Enrolling pharmacies in the program.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 9.</u>\n    </b> ORS 414.334 is amended to read:</p>\n   <p class=\"indent\">414.334. (1) The Oregon Health Authority shall adopt a <u class=\"amendmentInsertedText\">uniform</u> Practitioner-Managed Prescription Drug Plan for the medical assistance program <u class=\"amendmentInsertedText\">to be used by fee-for-service reimbursement and prescription drugs provided by coordinated care organizations</u> . The purpose of the plan is to ensure that enrollees in the medical assistance program receive the most effective prescription drug available at the best possible price.</p>\n   <p class=\"indent\">(2) In adopting the plan, the authority shall consider recommendations of the Pharmacy and Therapeutics Committee.</p>\n   <p class=\"indent\">(3) The authority shall consult with representatives of the regulatory boards and associations representing practitioners who are prescribers under the medical assistance program and ensure that practitioners receive educational materials and have access to training on the PractitionerManaged Prescription Drug Plan.</p>\n   <p class=\"indent\">(4) Notwithstanding the Practitioner-Managed Prescription Drug Plan adopted by the authority, a practitioner may prescribe any drug that the practitioner indicates is medically necessary for an enrollee as being the most effective available.</p>\n   <p class=\"indent\">(5) An enrollee may appeal to the authority a decision of a practitioner or the authority to not provide a prescription drug requested by the enrollee.</p>\n   <p class=\"indent\">(6) This section does not limit the decision of a practitioner as to the scope and duration of treatment of chronic conditions, including but not limited to arthritis, diabetes and asthma.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 10.</u>\n    </b> ORS 414.359 is amended to read:</p>\n   <p class=\"indent\">414.359. (1) The Mental Health Clinical Advisory Group is established in the Oregon Health Authority. The Mental Health Clinical Advisory Group shall develop evidence-based algorithms for mental health treatments, including treatments with mental health drugs based on:</p>\n   <p class=\"indent\">(a) The efficacy of the drug;</p>\n   <p class=\"indent\">(b) The cost of the drug;</p>\n   <p class=\"indent\">(c) Potential side effects of the drug;</p>\n   <p class=\"indent\">(d) A patient&rsquo;s profile; and</p>\n   <p class=\"indent\">(e) A patient&rsquo;s history with the drug.</p>\n   <p class=\"indent\">(2) The Mental Health Clinical Advisory Group consists of 18 members appointed by the authority as follows:</p>\n   <p class=\"indent\">(a) Two psychiatrists each with an active community practice;</p>\n   <p class=\"indent\">(b) One child and adolescent psychiatrist;</p>\n   <p class=\"indent\">(c) Two licensed clinical psychologists;</p>\n   <p class=\"indent\">(d) One psychiatric nurse practitioner with prescribing privileges;</p>\n   <p class=\"indent\">(e) Two primary care providers;</p>\n   <p class=\"indent\">(f) Two pharmacists, one of whom must have experience dispensing to long term care facilities and patients with special needs;</p>\n   <p class=\"indent\">(g) Two individuals, each representing a statewide mental health advocacy organization for children and adults with mental illness, who have experience as a consumer of mental health services or as a family member of a consumer of mental health services;</p>\n   <p class=\"indent\">(h) Two individuals each representing a coordinated care organization;</p>\n   <p class=\"indent\">(i) One consumer of mental health services;</p>\n   <p class=\"indent\">(j) One member of a federally recognized Oregon Indian tribe;</p>\n   <p class=\"indent\">(k) One member who represents the Department of Corrections who has a clinical background; and</p>\n   <p class=\"indent\">(L) One member who is a clinical psychiatrist and who represents the Oregon Psychiatric Access Line.</p>\n   <p class=\"indent\">(3) The Mental Health Clinical Advisory Group shall, in developing treatment algorithms, consider all of the following:</p>\n   <p class=\"indent\">(a) Peer-reviewed medical literature;</p>\n   <p class=\"indent\">(b) Observational studies;</p>\n   <p class=\"indent\">(c) Studies of health economics;</p>\n   <p class=\"indent\">(d) Input from patients and physicians; and</p>\n   <p class=\"indent\">(e) Any other information that the group deems appropriate.</p>\n   <p class=\"indent\">(4) The Mental Health Clinical Advisory Group shall make recommendations to the authority and the Pharmacy and Therapeutics Committee, including but not limited to:</p>\n   <p class=\"indent\">(a) Implementation of evidence-based algorithms.</p>\n   <p class=\"indent\">(b) Any changes needed to <strike class=\"amendmentDeletedText\">any preferred drug list used by the authority</strike>\n    <u class=\"amendmentInsertedText\">the PractitionerManaged Prescription Drug Plan or any preferred drug list used by the authority or a coordinated care organization</u>.</p>\n   <p class=\"indent\">(c) Practice guidelines for the treatment of mental health disorders with mental health drugs.</p>\n   <p class=\"indent\">(d) Coordinating the work of the group with an entity that offers a psychiatric advice hotline.</p>\n   <p class=\"indent\">(5) Recommendations of the Mental Health Clinical Advisory Group shall be posted to the website of the authority no later than 30 days after the group approves the recommendations.</p>\n   <p class=\"indent\">(6) No later than December 31 of each year, the Mental Health Clinical Advisory Group shall report to the interim committees of the Legislative Assembly related to health on recommendations made to the authority under subsection (4) of this section and the report may include recommendations for legislation.</p>\n   <p class=\"indent\">(7) A member of the Mental Health Clinical Advisory Group is not entitled to compensation but may be reimbursed for necessary travel expenses incurred in the performance of the member&rsquo;s official duties.</p>\n   <p class=\"indent\">(8) The Mental Health Clinical Advisory Group shall select one of its members as chairperson and another as vice chairperson, for terms and with duties and powers necessary for the performance of the functions of the group.</p>\n   <p class=\"indent\">(9) A majority of the members of the Mental Health Clinical Advisory Group constitutes a quorum for the transaction of business.</p>\n   <p class=\"indent\">(10) The Mental Health Clinical Advisory Group shall meet at least once every two months at a time and place determined by the chairperson. The group also may meet at other times and places specified by the call of the chairperson or of a majority of the members of the group. The group may meet in executive session when discussing factors listed in subsection (1) of this section.</p>\n   <p class=\"indent\">(11) All agencies of state government, as defined in ORS 174.111, are directed to assist the Mental Health Clinical Advisory Group in the performance of duties of the group and, to the extent permitted by laws relating to confidentiality, to furnish information and advice the members of the group consider necessary to perform their duties.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 11.</u>\n    </b> ORS 413.032 is amended to read:</p>\n   <p class=\"indent\">413.032. (1) The Oregon Health Authority is established. The authority shall:</p>\n   <p class=\"indent\">(a) Carry out policies adopted by the Oregon Health Policy Board;</p>\n   <p class=\"indent\">(b) Administer the Oregon Integrated and Coordinated Health Care Delivery System established in ORS 414.570 and the COFA Dental Program established in ORS 413.614;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c) Administer the Oregon Prescription Drug Program;</strike>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(d)</strike>\n    <u class=\"amendmentInsertedText\">(c)</u> Develop the policies for and the provision of publicly funded medical care and medical assistance in this state;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(e)</strike>\n    <u class=\"amendmentInsertedText\">(d)</u> Develop the policies for and the provision of mental health treatment and treatment of addictions;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(f)</strike>\n    <u class=\"amendmentInsertedText\">(e)</u> Assess, promote and protect the health of the public as specified by state and federal law;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(g)</strike>\n    <u class=\"amendmentInsertedText\">(f)</u> Provide regular reports to the board with respect to the performance of health services contractors serving recipients of medical assistance, including reports of trends in health services and enrollee satisfaction;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(h)</strike>\n    <u class=\"amendmentInsertedText\">(g)</u> Guide and support, with the authorization of the board, community-centered health initiatives designed to address critical risk factors, especially those that contribute to chronic disease;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(i)</strike>\n    <u class=\"amendmentInsertedText\">(h)</u> Be the state Medicaid agency for the administration of funds from Titles XIX and XXI of the Social Security Act and administer medical assistance under ORS chapter 414;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(j)</strike>\n    <u class=\"amendmentInsertedText\">(i)</u> In consultation with the Director of the Department of Consumer and Business Services, periodically review and recommend standards and methodologies to the Legislative Assembly for:</p>\n   <p class=\"indent\">(A) Review of administrative expenses of health insurers;</p>\n   <p class=\"indent\">(B) Approval of rates; and</p>\n   <p class=\"indent\">(C) Enforcement of rating rules adopted by the Department of Consumer and Business Services;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(k)</strike>\n    <u class=\"amendmentInsertedText\">(j)</u> Structure reimbursement rates for providers that serve recipients of medical assistance to reward comprehensive management of diseases, quality outcomes and the efficient use of resources and to promote cost-effective procedures, services and programs including, without limitation, preventive health, dental and primary care services, web-based office visits, telephone consultations and telemedicine consultations;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(L)</strike>\n    <u class=\"amendmentInsertedText\">(k)</u> Guide and support community three-share agreements in which an employer, state or local government and an individual all contribute a portion of a premium for a community-centered health initiative or for insurance coverage;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(m)</strike>\n    <u class=\"amendmentInsertedText\">(L)</u> Develop, in consultation with the Department of Consumer and Business Services, one or more products designed to provide more affordable options for the small group market;</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(n)</strike>\n    <u class=\"amendmentInsertedText\">(m)</u> Implement policies and programs to expand the skilled, diverse workforce as described in ORS 414.018 (4); and</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(o)</strike>\n    <u class=\"amendmentInsertedText\">(n)</u> Implement a process for collecting the health outcome and quality measure data identified by the Health Plan Quality Metrics Committee and the Behavioral Health Committee and report the data to the Oregon Health Policy Board.</p>\n   <p class=\"indent\">(2) The Oregon Health Authority is authorized to:</p>\n   <p class=\"indent\">(a) Create an all-claims, all-payer database to collect health care data and monitor and evaluate health care reform in Oregon and to provide comparative cost and quality information to consumers, providers and purchasers of health care about Oregon&rsquo;s health care systems and health plan networks in order to provide comparative information to consumers.</p>\n   <p class=\"indent\">(b) Develop uniform contracting standards for the purchase of health care, including the following:</p>\n   <p class=\"indent\">(A) Uniform quality standards and performance measures;</p>\n   <p class=\"indent\">(B) Evidence-based guidelines for major chronic disease management and health care services with unexplained variations in frequency or cost;</p>\n   <p class=\"indent\">(C) Evidence-based effectiveness guidelines for select new technologies and medical equipment;</p>\n   <p class=\"indent\">(D) A statewide drug formulary that may be used by publicly funded health benefit plans; and</p>\n   <p class=\"indent\">(E) Standards that accept and consider tribal-based practices for mental health and substance abuse prevention, counseling and treatment for persons who are Native American or Alaska Native as equivalent to evidence-based practices.</p>\n   <p class=\"indent\">(3) The enumeration of duties, functions and powers in this section is not intended to be exclusive nor to limit the duties, functions and powers imposed on or vested in the Oregon Health Authority by ORS 413.006 to 413.042, 415.012 to 415.430, 415.501, 741.001 to 741.540, 741.802 and 741.900 or by other statutes.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 12.</u>\n    </b> ORS 413.011 is amended to read:</p>\n   <p class=\"indent\">413.011. (1) The duties of the Oregon Health Policy Board are to:</p>\n   <p class=\"indent\">(a) Be the policy-making and oversight body for the Oregon Health Authority established in ORS 413.032 and all of the authority&rsquo;s departmental divisions.</p>\n   <p class=\"indent\">(b) Develop and submit a plan to the Legislative Assembly to provide and fund access to affordable, quality health care for all Oregonians.</p>\n   <p class=\"indent\">(c) Develop a program to provide health insurance premium assistance to all low and moderate income individuals who are legal residents of Oregon.</p>\n   <p class=\"indent\">(d) Publish health outcome and quality measure data collected by the Oregon Health Authority at aggregate levels that do not disclose information otherwise protected by law. The information published must report, for each coordinated care organization and each health benefit plan sold through the health insurance exchange or offered by the Oregon Educators Benefit Board or the Public Employees&rsquo; Benefit Board:</p>\n   <p class=\"indent\">(A) Quality measures;</p>\n   <p class=\"indent\">(B) Costs;</p>\n   <p class=\"indent\">(C) Health outcomes; and</p>\n   <p class=\"indent\">(D) Other information that is necessary for members of the public to evaluate the value of health services delivered by each coordinated care organization and by each health benefit plan.</p>\n   <p class=\"indent\">(e) Establish evidence-based clinical standards and practice guidelines that may be used by providers.</p>\n   <p class=\"indent\">(f) Approve and monitor community-centered health initiatives described in ORS 413.032 <strike class=\"amendmentDeletedText\">(1)(h)</strike>\n    <u class=\"amendmentInsertedText\">(1)(g)</u> that are consistent with public health goals, strategies, programs and performance standards adopted by the Oregon Health Policy Board to improve the health of all Oregonians, and to regularly report to the Legislative Assembly on the accomplishments and needed changes to the initiatives.</p>\n   <p class=\"indent\">(g) Establish cost containment mechanisms to reduce health care costs.</p>\n   <p class=\"indent\">(h) Ensure that Oregon&rsquo;s health care workforce is sufficient in numbers and training to meet the demand that will be created by the expansion in health coverage, health care system transformations, an increasingly diverse population and an aging workforce.</p>\n   <p class=\"indent\">(i) Work with the Oregon congressional delegation to advance the adoption of changes in federal law or policy to promote Oregon&rsquo;s comprehensive health reform plan.</p>\n   <p class=\"indent\">(j) Establish a health benefit package in accordance with ORS 741.340 to be used as the baseline for all health benefit plans offered through the health insurance exchange.</p>\n   <p class=\"indent\">(k) Investigate and report annually to the Legislative Assembly on the feasibility and advisability of future changes to the health insurance market in Oregon, including but not limited to the following:</p>\n   <p class=\"indent\">(A) A requirement for every resident to have health insurance coverage.</p>\n   <p class=\"indent\">(B) A payroll tax as a means to encourage employers to continue providing health insurance to their employees.</p>\n   <p class=\"indent\">(L) Meet cost-containment goals by structuring reimbursement rates to reward comprehensive management of diseases, quality outcomes and the efficient use of resources by promoting costeffective procedures, services and programs including, without limitation, preventive health, dental and primary care services, web-based office visits, telephone consultations and telemedicine consultations.</p>\n   <p class=\"indent\">(m) Oversee the expenditure of moneys from the Health Care Provider Incentive Fund to support grants to primary care providers and rural health practitioners, to increase the number of primary care educators and to support efforts to create and develop career ladder opportunities.</p>\n   <p class=\"indent\">(n) Work with the Public Health Benefit Purchasers Committee, administrators of the medical assistance program and the Department of Corrections to identify uniform contracting standards for health benefit plans that achieve maximum quality and cost outcomes and align the contracting standards for all state programs to the greatest extent practicable.</p>\n   <p class=\"indent\">(o) Work with the Health Information Technology Oversight Council to foster health information technology systems and practices that promote the Oregon Integrated and Coordinated Health Care Delivery System established by ORS 414.570 and align health information technology systems and practices across this state.</p>\n   <p class=\"indent\">(2) The Oregon Health Policy Board is authorized to:</p>\n   <p class=\"indent\">(a) Subject to the approval of the Governor, organize and reorganize the authority as the board considers necessary to properly conduct the work of the authority.</p>\n   <p class=\"indent\">(b) Submit directly to the Legislative Counsel, no later than October 1 of each even-numbered year, requests for measures necessary to provide statutory authorization to carry out any of the board&rsquo;s duties or to implement any of the board&rsquo;s recommendations. The measures may be filed prior to the beginning of the legislative session in accordance with the rules of the House of Representatives and the Senate.</p>\n   <p class=\"indent\">(3) If the board or the authority is unable to perform, in whole or in part, any of the duties described in ORS 413.006 to 413.042 and 741.340 without federal approval, the authority is authorized to request, in accordance with ORS 413.072, waivers or other approval necessary to perform those duties. The authority shall implement any portions of those duties not requiring legislative authority or federal approval, to the extent practicable.</p>\n   <p class=\"indent\">(4) The enumeration of duties, functions and powers in this section is not intended to be exclusive nor to limit the duties, functions and powers imposed on the board by ORS 413.006 to 413.042 and 741.340 and by other statutes.</p>\n   <p class=\"indent\">(5) The board shall consult with the Department of Consumer and Business Services in completing the tasks set forth in subsection (1)(j) and (k)(A) of this section.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 13.</u>\n    </b> ORS 410.080 is amended to read:</p>\n   <p class=\"indent\">410.080. (1) The Department of Human Services is the designated single state agency for all federal programs under ORS 409.010 and 410.040 to 410.300 except that the Oregon Health Authority is the single state agency responsible for supervising the administration of all programs funded by Title XIX or Title XXI of the Social Security Act as provided in ORS 413.032 <strike class=\"amendmentDeletedText\">(1)(i)</strike>\n    <u class=\"amendmentInsertedText\">(1)(h)</u> .</p>\n   <p class=\"indent\">(2) Except as provided in ORS 410.070 (2)(d) and 410.100, the administration of services to clients under ORS 410.040 to 410.300 shall be through area agencies, and shall comply with all applicable federal regulations.</p>\n   <p class=\"indent\">\n    <b>\n     <u>SECTION 14.</u>\n    </b>\n    <u class=\"amendmentInsertedText\">(1) Sections 2 to 4 of this 2025 Act and the amendments to ORS 410.080, 413.011, 413.032, 414.312, 414.314, 414.318, 414.320, 414.334 and 414.359 by sections 5 to 13 of this 2025 Act become operative on January 1, 2026.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) The Oregon Department of Administrative Services may take any action before the operative date specified in subsection (1) of this section that is necessary for the department to exercise, on and after the operative date specified in subsection (1) of this section, all the duties, functions and powers conferred on the department by sections 2 to 4 of this 2025 Act and the amendments to ORS 410.080, 413.011, 413.032, 414.312, 414.314, 414.318, 414.320, 414.334 and 414.359 by sections 5 to 13 of this 2025 Act.</u>\n   </p>\n   <effective_clause>\n    <p class=\"indent\">\n     <b>\n      <u>SECTION 15.</u>\n     </b>\n     <u class=\"amendmentInsertedText\">This 2025 Act takes effect on the 91st day after the date on which the 2025 regular session of the Eighty-third Legislative Assembly adjourns sine die.</u>\n    </p>\n   </effective_clause>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 OR H 3613 | | Author: | Nelson  \n---|---  \nVersion: | Introduced  \nVersion Date: | 02/18/2025  \n  \n83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session\n\n**House Bill 3613**\n\nSponsored by Representative NELSON\n\n**SUMMARY**\n\nThe following summary is not prepared by the sponsors of the measure and is\nnot a part of the body thereof subject to consideration by the Legislative\nAssembly. It is an editor's brief statement of the essential features of the\nmeasure as introduced. The statement includes a measure digest written in\ncompliance with applicable readability standards.\n\nDigest: Creates the OPP and moves the OPDP to OPP. Makes some changes to OPDP\nand PMPDP. Takes effect 91 days after session ends. (Flesch Readability Score:\n88.4).\n\nCreates the Office of Pharmaceutical Purchasing within the Oregon Department\nof Administrative Services to support multiagency and multistate collaborative\npurchasing of pharmaceuticals, drive down the cost of prescription drugs for\nresidents of this state and manage the Oregon Prescription Drug Program.\n\nCreates an advisory board within the Office of Pharmaceutical Purchasing to\nassist in coordinating pharmaceutical purchasing across state agencies and\nprograms.\n\nTransfers the Oregon Prescription Drug Program from the Oregon Health\nAuthority to the Office of Pharmaceutical Purchasing and modifies the program,\nincluding by requiring certain agencies and coordinated care organizations to\nparticipate.\n\nClarifies that a uniform Practitioner-Managed Prescription Drug Plan and\npreferred drug list should be used in both fee-for-service reimbursements and\nprescription drugs provided by coordinated care organizations.\n\nTakes effect on the 91st day following adjournment sine die.\n\n**A BILL FOR AN ACT**\n\nRelating to pharmaceutical purchasing; creating new provisions; amending ORS\n410.080, 413.011, 413.032, 414.312, 414.314, 414.318, 414.320, 414.334 and\n414.359; and prescribing an effective date.\n\n**Be It Enacted by the People of the State of Oregon:**\n\n**_SECTION 1._ ** _Sections 2 to 4 of this 2025 Act are added to and made a\npart of ORS chapter 414._\n\n**_SECTION 2._ ** _(1) The Office of Pharmaceutical Purchasing is established\nin the Oregon Department of Administrative Services to support multiagency and\nmultistate collaborative purchasing of pharmaceuticals and drive down the cost\nof prescription drugs for residents of this state._\n\n_(2) The purpose of the office is to:_\n\n_(a) Improve coordination in pharmaceutical purchasing to reduce costs for\ntaxpayers and consumers;_\n\n_(b) Leverage the state 's collective purchasing power to promote cost\nsavings, efficiency and transparency while maintaining excellent service of\neach purchasing entity;_\n\n_(c) Enhance the Oregon Prescription Drug Program and integrate uniform\nstandards across this state 's medical assistance program that will further\nreduce administrative burden and optimize resource utilization;_\n\n_(d) Establish and administer a multistate prescription drug purchasing\nconsortium; and_\n\n_(e) Administer all intergovernmental and interagency agreements necessary to\nachieve the office 's purposes described in this subsection._\n\n_(3) The office shall:_\n\n_(a) Provide oversight for all state pharmaceutical purchasing and state\ncontracts related to pharmaceutical procurement and payments;_\n\n_(b) Administer the Oregon Prescription Drug Program;_\n\n_(c) Develop and enforce rules for statewide purchasing agreements, payments\nmade to pharmacies and procurement standards;_\n\n_(d) Monitor state pharmaceutical purchasing by examining the data collected\nand maintained by state agencies related to pharmaceutical purchases;_\n\n_(e) Coordinate and facilitate the work of the advisory board established in\nsection 3 of this 2025 Act; and_\n\n_(f) No later than October 1 of each year, submit a report to the Legislative\nAssembly in the manner provided in ORS 192.245, after consultation from the\nadvisory board, that includes at a minimum:_\n\n_(i) Total pharmaceutical expenditures by agency and program;_\n\n_(ii) Identification of fragmentation in state pharmaceutical purchasing;_\n\n_(iii) Current procurement practices of each agency and program;_\n\n_(iv) Barriers to effective defragmentation and leveraging of purchasing\npower; and_\n\n_(v) Recommendations for legislative action to reduce costs and improve\ncoordination._\n\n_(4) The Director of the Department of Administrative Services shall appoint\nan administrator for the office and all subordinate officers and employees of\nthe office._\n\n**_SECTION 3._ ** _(1) There is created in the Office of Pharmaceutical\nPurchasing the Office of Pharmaceutical Purchasing Advisory Board. The purpose\nof the advisory board is to coordinate pharmaceutical purchasing across state\nagencies and programs._\n\n_(2) The administrator of the Office of Pharmaceutical Purchasing shall serve\nas chair of the advisory board and, after consultation with the Governor,\nshall appoint the following members:_\n\n_(a) The executive director of the Oregon Educators Benefit Board;_\n\n_(b) The executive director of the Public Employees ' Benefit Board;_\n\n_(c) The executive director of the Public Employees Retirement System;_\n\n_(d) The executive director of the Prescription Drug Affordability Board; and_\n\n_(e) A member representing each of the following entities:_\n\n_(A) The Department of Corrections;_\n\n_(B) The Oregon State Hospital;_\n\n_(C) The Oregon Health Authority pharmacy policy and programs office;_\n\n_(D) Local health departments;_\n\n_(E) The Universal Health Plan Governance Board;_\n\n_(F) Oregon State University College of Pharmacy; and_\n\n_(G) An Oregon Health Authority public health representative._\n\n_(3) With approval from a majority of the advisory board members, the\nadministrator may appoint additional members to the advisory board._\n\n_(4) One less than a majority of the advisory board constitutes a quorum for\nthe transaction of business._\n\n_(5) The advisory board shall be considered a public body and is subject to\nORS 192.610 to 192.705._\n\n_(6) The advisory board shall:_\n\n_(a) Meet at least once per quarter;_\n\n_(b) Review the recommendations made by the Office of Pharmaceutical\nPurchasing regarding defragmentation;_\n\n_(c) Communicate to the office the barriers and challenges that inhibit\neffective leveraging of pharmaceutical purchasing power;_\n\n_(d) Develop legislative recommendations to reduce fragmentation and improve\nOregon 's pharmaceutical purchasing power;_\n\n_(e) Review the multistate purchasing consortium growth and savings reports\nand advise the administrator of the office; and_\n\n_(f) Serve as stewards of Oregon tax dollars to ensure that every agency and\nprogram maintains service excellence while effectively leveraging Oregon 's\ncollective pharmaceutical purchasing power._\n\n**_SECTION 4._ ** _The Office of Pharmaceutical Purchasing shall adopt rules\nto carry out the provisions of sections 2 and 3 of this 2025 Act._\n\n**_SECTION 5._ ** ORS 414.312 is amended to read:\n\n414.312. (1) As used in ORS 414.312 to 414.318:\n\n(a) \"Pharmacy benefit manager\" means an entity that negotiates and executes\ncontracts with pharmacies, manages preferred drug lists, negotiates rebates\nwith prescription drug manufacturers and serves as an intermediary between the\nOregon Prescription Drug Program, prescription drug manufacturers and\npharmacies.\n\n(b) \"Prescription drug claims processor\" means an entity that processes and\npays prescription drug claims, adjudicates pharmacy claims, transmits\nprescription drug prices and claims data between pharmacies and the Oregon\nPrescription Drug Program and processes related payments to pharmacies.\n\n(c) \"Program price\" means the reimbursement rates and prescription drug prices\nestablished by the administrator of the Oregon Prescription Drug Program.\n\n(2) The Oregon Prescription Drug Program is established in the ~~Oregon Health\nAuthority~~ _Office of Pharmaceutical Purchasing_ . The purpose of the program\nis to:\n\n(a) Purchase prescription drugs, replenish prescription drugs dispensed or\nreimburse pharmacies for prescription drugs in order to receive discounted\nprices and rebates;\n\n(b) Make prescription drugs available at the lowest possible cost to\nparticipants in the program as a means to promote health;\n\n(c) Maintain a list of prescription drugs recommended as the most effective\nprescription drugs available at the best possible prices; and\n\n(d) Promote health through the purchase and provision of discount prescription\ndrugs and coordination of comprehensive prescription benefit services for\neligible entities and members.\n\n(3) The ~~Director of the Oregon Health Authority~~ _administrator of the\noffice_ shall appoint an administrator of the Oregon Prescription Drug\nProgram. The administrator may:\n\n(a) Negotiate price discounts and rebates on prescription drugs with\nprescription drug manufacturers or group purchasing organizations;\n\n(b) Purchase prescription drugs on behalf of individuals and entities that\nparticipate in the program;\n\n(c) Contract with a prescription drug claims processor to adjudicate pharmacy\nclaims and transmit program prices to pharmacies;\n\n(d) Determine program prices and reimburse or replenish pharmacies for\nprescription drugs dispensed or transferred;\n\n(e) Adopt and implement a preferred drug list for the program;\n\n(f) Develop a system for allocating and distributing the operational costs of\nthe program and any rebates obtained to participants of the program; and\n\n(g) Cooperate with other states or regional consortia in the bulk purchase of\nprescription drugs.\n\n(4) The following individuals or entities may participate in the program:\n\n(a) Public Employees' Benefit Board, Oregon Educators Benefit Board and Public\nEmployees Retirement System;\n\n(b) Local governments as defined in ORS 174.116 and special government bodies\nas defined in ORS 174.117 that directly or indirectly purchase prescription\ndrugs;\n\n(c) Oregon Health and Science University established under ORS 353.020;\n\n~~(d) State agencies that directly or indirectly purchase prescription drugs,\nincluding agencies that dispense prescription drugs directly to persons in\nstate-operated facilities;~~\n\n~~(e)~~ _(d)_ Residents of this state who lack or are underinsured for\nprescription drug coverage;\n\n~~(f)~~ _(e)_ Private entities; and\n\n~~(g)~~ _(f)_ Labor organizations.\n\n_(5) The following individuals or entities must participate in the program\nunless the individual or entity can demonstrate that a lower price is\navailable for the same prescription drug without utilizing the program:_\n\n_(a) State agencies that directly or indirectly purchase prescription drugs,\nincluding agencies that dispense prescription drugs directly to persons in\nstate-operated facilities; and_\n\n_(b) Coordinated care organizations._\n\n~~(5)~~ _(6)_ The administrator may establish different program prices for\npharmacies in rural areas to maintain statewide access to the program.\n\n~~(6)~~ _(7)_ The administrator may establish the terms and conditions for a\npharmacy to enroll in the program. A licensed pharmacy that is willing to\naccept the terms and conditions established by the administrator may apply to\nenroll in the program.\n\n~~(7)~~ _(8)_ Except as provided in subsection ~~(8)~~ _(9)_ of this section,\nthe administrator may not:\n\n~~(a) Contract with a pharmacy benefit manager;~~\n\n~~(b)~~ _(a)_ Establish a state-managed wholesale or retail drug distribution\nor dispensing system; or\n\n~~(c)~~ _(b)_ Require pharmacies to maintain or allocate separate inventories\nfor prescription drugs dispensed through the program.\n\n~~(8)~~ _(9)_ The administrator shall contract with one or more entities to\nperform any of the functions of the program, including but not limited to:\n\n(a) Contracting with a pharmacy benefit manager and directly or indirectly\nwith such pharmacy networks as the administrator considers necessary to\nmaintain statewide access to the program.\n\n(b) Negotiating with prescription drug manufacturers on behalf of the\nadministrator.\n\n~~(9)~~ _(10)_ Notwithstanding subsection ~~(4)(e)~~ _(4)(d)_ of this section,\nindividuals who are eligible for Medicare Part D prescription drug coverage\nmay participate in the program.\n\n~~(10)~~ _(11)_ The program may contract with vendors as necessary to utilize\ndiscount purchasing programs, including but not limited to group purchasing\norganizations established to meet the criteria of the Nonprofit Institutions\nAct, 15 U.S.C. 13c, or that are exempt under the Robinson-Patman Act, 15\nU.S.C. 13.\n\n**_SECTION 6._ ** ORS 414.314 is amended to read:\n\n414.314. (1) An individual or entity described in ORS 414.312 (4) may apply to\nparticipate in the Oregon Prescription Drug Program. Participants shall apply\non an application provided by the ~~Oregon Health Authority~~ _Office of\nPharmaceutical Purchasing_ . The ~~authority~~ _office_ may charge\nparticipants a nominal fee to participate in the program. The ~~authority~~\n_office_ shall issue a prescription drug identification card to participants\nof the program.\n\n(2) The ~~authority~~ _office_ shall provide a mechanism to calculate and\ntransmit the program prices for prescription drugs to a pharmacy. The pharmacy\nshall charge the participant the program price for a prescription drug.\n\n(3) A pharmacy may charge the participant the professional dispensing fee set\nby the _Oregon Health_ Authority.\n\n(4) Prescription drug identification cards issued under this section must\ncontain the information necessary for proper claims adjudication or\ntransmission of price data.\n\n**_SECTION 7._ ** ORS 414.318 is amended to read:\n\n414.318. The Prescription Drug Purchasing Fund is established separate and\ndistinct from the General Fund. The Prescription Drug Purchasing Fund shall\nconsist of moneys appropriated to the fund by the Legislative Assembly and\nmoneys received by the ~~Oregon Health Authority~~ _Oregon Department of\nAdministrative Services_ for the purposes established in this section in the\nform of gifts, grants, bequests, endowments or donations. The moneys in the\nPrescription Drug Purchasing Fund are continuously appropriated to the\n~~authority~~ _department_ and shall be used to purchase prescription drugs,\nreimburse pharmacies for prescription drugs and reimburse the ~~authority~~\n_department_ for the costs of administering the Oregon Prescription Drug\nProgram, including contracted services costs, computer costs, professional\ndispensing fees paid to retail pharmacies and other reasonable program costs.\nInterest earned on the fund shall be credited to the fund.\n\n**_SECTION 8._ ** ORS 414.320 is amended to read:\n\n414.320. The ~~Oregon Health Authority~~ _Office of Pharmaceutical Purchasing_\nshall adopt rules to implement and administer ORS 414.312 to 414.318. The\nrules shall include but are not limited to establishing procedures for:\n\n(1) Issuing prescription drug identification cards to individuals and entities\nthat participate in the Oregon Prescription Drug Program; and\n\n(2) Enrolling pharmacies in the program.\n\n**_SECTION 9._ ** ORS 414.334 is amended to read:\n\n414.334. (1) The Oregon Health Authority shall adopt a _uniform_ Practitioner-\nManaged Prescription Drug Plan for the medical assistance program _to be used\nby fee-for-service reimbursement and prescription drugs provided by\ncoordinated care organizations_ . The purpose of the plan is to ensure that\nenrollees in the medical assistance program receive the most effective\nprescription drug available at the best possible price.\n\n(2) In adopting the plan, the authority shall consider recommendations of the\nPharmacy and Therapeutics Committee.\n\n(3) The authority shall consult with representatives of the regulatory boards\nand associations representing practitioners who are prescribers under the\nmedical assistance program and ensure that practitioners receive educational\nmaterials and have access to training on the PractitionerManaged Prescription\nDrug Plan.\n\n(4) Notwithstanding the Practitioner-Managed Prescription Drug Plan adopted by\nthe authority, a practitioner may prescribe any drug that the practitioner\nindicates is medically necessary for an enrollee as being the most effective\navailable.\n\n(5) An enrollee may appeal to the authority a decision of a practitioner or\nthe authority to not provide a prescription drug requested by the enrollee.\n\n(6) This section does not limit the decision of a practitioner as to the scope\nand duration of treatment of chronic conditions, including but not limited to\narthritis, diabetes and asthma.\n\n**_SECTION 10._ ** ORS 414.359 is amended to read:\n\n414.359. (1) The Mental Health Clinical Advisory Group is established in the\nOregon Health Authority. The Mental Health Clinical Advisory Group shall\ndevelop evidence-based algorithms for mental health treatments, including\ntreatments with mental health drugs based on:\n\n(a) The efficacy of the drug;\n\n(b) The cost of the drug;\n\n(c) Potential side effects of the drug;\n\n(d) A patient's profile; and\n\n(e) A patient's history with the drug.\n\n(2) The Mental Health Clinical Advisory Group consists of 18 members appointed\nby the authority as follows:\n\n(a) Two psychiatrists each with an active community practice;\n\n(b) One child and adolescent psychiatrist;\n\n(c) Two licensed clinical psychologists;\n\n(d) One psychiatric nurse practitioner with prescribing privileges;\n\n(e) Two primary care providers;\n\n(f) Two pharmacists, one of whom must have experience dispensing to long term\ncare facilities and patients with special needs;\n\n(g) Two individuals, each representing a statewide mental health advocacy\norganization for children and adults with mental illness, who have experience\nas a consumer of mental health services or as a family member of a consumer of\nmental health services;\n\n(h) Two individuals each representing a coordinated care organization;\n\n(i) One consumer of mental health services;\n\n(j) One member of a federally recognized Oregon Indian tribe;\n\n(k) One member who represents the Department of Corrections who has a clinical\nbackground; and\n\n(L) One member who is a clinical psychiatrist and who represents the Oregon\nPsychiatric Access Line.\n\n(3) The Mental Health Clinical Advisory Group shall, in developing treatment\nalgorithms, consider all of the following:\n\n(a) Peer-reviewed medical literature;\n\n(b) Observational studies;\n\n(c) Studies of health economics;\n\n(d) Input from patients and physicians; and\n\n(e) Any other information that the group deems appropriate.\n\n(4) The Mental Health Clinical Advisory Group shall make recommendations to\nthe authority and the Pharmacy and Therapeutics Committee, including but not\nlimited to:\n\n(a) Implementation of evidence-based algorithms.\n\n(b) Any changes needed to ~~any preferred drug list used by the authority~~\n_the PractitionerManaged Prescription Drug Plan or any preferred drug list\nused by the authority or a coordinated care organization_.\n\n(c) Practice guidelines for the treatment of mental health disorders with\nmental health drugs.\n\n(d) Coordinating the work of the group with an entity that offers a\npsychiatric advice hotline.\n\n(5) Recommendations of the Mental Health Clinical Advisory Group shall be\nposted to the website of the authority no later than 30 days after the group\napproves the recommendations.\n\n(6) No later than December 31 of each year, the Mental Health Clinical\nAdvisory Group shall report to the interim committees of the Legislative\nAssembly related to health on recommendations made to the authority under\nsubsection (4) of this section and the report may include recommendations for\nlegislation.\n\n(7) A member of the Mental Health Clinical Advisory Group is not entitled to\ncompensation but may be reimbursed for necessary travel expenses incurred in\nthe performance of the member's official duties.\n\n(8) The Mental Health Clinical Advisory Group shall select one of its members\nas chairperson and another as vice chairperson, for terms and with duties and\npowers necessary for the performance of the functions of the group.\n\n(9) A majority of the members of the Mental Health Clinical Advisory Group\nconstitutes a quorum for the transaction of business.\n\n(10) The Mental Health Clinical Advisory Group shall meet at least once every\ntwo months at a time and place determined by the chairperson. The group also\nmay meet at other times and places specified by the call of the chairperson or\nof a majority of the members of the group. The group may meet in executive\nsession when discussing factors listed in subsection (1) of this section.\n\n(11) All agencies of state government, as defined in ORS 174.111, are directed\nto assist the Mental Health Clinical Advisory Group in the performance of\nduties of the group and, to the extent permitted by laws relating to\nconfidentiality, to furnish information and advice the members of the group\nconsider necessary to perform their duties.\n\n**_SECTION 11._ ** ORS 413.032 is amended to read:\n\n413.032. (1) The Oregon Health Authority is established. The authority shall:\n\n(a) Carry out policies adopted by the Oregon Health Policy Board;\n\n(b) Administer the Oregon Integrated and Coordinated Health Care Delivery\nSystem established in ORS 414.570 and the COFA Dental Program established in\nORS 413.614;\n\n~~(c) Administer the Oregon Prescription Drug Program;~~\n\n~~(d)~~ _(c)_ Develop the policies for and the provision of publicly funded\nmedical care and medical assistance in this state;\n\n~~(e)~~ _(d)_ Develop the policies for and the provision of mental health\ntreatment and treatment of addictions;\n\n~~(f)~~ _(e)_ Assess, promote and protect the health of the public as\nspecified by state and federal law;\n\n~~(g)~~ _(f)_ Provide regular reports to the board with respect to the\nperformance of health services contractors serving recipients of medical\nassistance, including reports of trends in health services and enrollee\nsatisfaction;\n\n~~(h)~~ _(g)_ Guide and support, with the authorization of the board,\ncommunity-centered health initiatives designed to address critical risk\nfactors, especially those that contribute to chronic disease;\n\n~~(i)~~ _(h)_ Be the state Medicaid agency for the administration of funds\nfrom Titles XIX and XXI of the Social Security Act and administer medical\nassistance under ORS chapter 414;\n\n~~(j)~~ _(i)_ In consultation with the Director of the Department of Consumer\nand Business Services, periodically review and recommend standards and\nmethodologies to the Legislative Assembly for:\n\n(A) Review of administrative expenses of health insurers;\n\n(B) Approval of rates; and\n\n(C) Enforcement of rating rules adopted by the Department of Consumer and\nBusiness Services;\n\n~~(k)~~ _(j)_ Structure reimbursement rates for providers that serve\nrecipients of medical assistance to reward comprehensive management of\ndiseases, quality outcomes and the efficient use of resources and to promote\ncost-effective procedures, services and programs including, without\nlimitation, preventive health, dental and primary care services, web-based\noffice visits, telephone consultations and telemedicine consultations;\n\n~~(L)~~ _(k)_ Guide and support community three-share agreements in which an\nemployer, state or local government and an individual all contribute a portion\nof a premium for a community-centered health initiative or for insurance\ncoverage;\n\n~~(m)~~ _(L)_ Develop, in consultation with the Department of Consumer and\nBusiness Services, one or more products designed to provide more affordable\noptions for the small group market;\n\n~~(n)~~ _(m)_ Implement policies and programs to expand the skilled, diverse\nworkforce as described in ORS 414.018 (4); and\n\n~~(o)~~ _(n)_ Implement a process for collecting the health outcome and\nquality measure data identified by the Health Plan Quality Metrics Committee\nand the Behavioral Health Committee and report the data to the Oregon Health\nPolicy Board.\n\n(2) The Oregon Health Authority is authorized to:\n\n(a) Create an all-claims, all-payer database to collect health care data and\nmonitor and evaluate health care reform in Oregon and to provide comparative\ncost and quality information to consumers, providers and purchasers of health\ncare about Oregon's health care systems and health plan networks in order to\nprovide comparative information to consumers.\n\n(b) Develop uniform contracting standards for the purchase of health care,\nincluding the following:\n\n(A) Uniform quality standards and performance measures;\n\n(B) Evidence-based guidelines for major chronic disease management and health\ncare services with unexplained variations in frequency or cost;\n\n(C) Evidence-based effectiveness guidelines for select new technologies and\nmedical equipment;\n\n(D) A statewide drug formulary that may be used by publicly funded health\nbenefit plans; and\n\n(E) Standards that accept and consider tribal-based practices for mental\nhealth and substance abuse prevention, counseling and treatment for persons\nwho are Native American or Alaska Native as equivalent to evidence-based\npractices.\n\n(3) The enumeration of duties, functions and powers in this section is not\nintended to be exclusive nor to limit the duties, functions and powers imposed\non or vested in the Oregon Health Authority by ORS 413.006 to 413.042, 415.012\nto 415.430, 415.501, 741.001 to 741.540, 741.802 and 741.900 or by other\nstatutes.\n\n**_SECTION 12._ ** ORS 413.011 is amended to read:\n\n413.011. (1) The duties of the Oregon Health Policy Board are to:\n\n(a) Be the policy-making and oversight body for the Oregon Health Authority\nestablished in ORS 413.032 and all of the authority's departmental divisions.\n\n(b) Develop and submit a plan to the Legislative Assembly to provide and fund\naccess to affordable, quality health care for all Oregonians.\n\n(c) Develop a program to provide health insurance premium assistance to all\nlow and moderate income individuals who are legal residents of Oregon.\n\n(d) Publish health outcome and quality measure data collected by the Oregon\nHealth Authority at aggregate levels that do not disclose information\notherwise protected by law. The information published must report, for each\ncoordinated care organization and each health benefit plan sold through the\nhealth insurance exchange or offered by the Oregon Educators Benefit Board or\nthe Public Employees' Benefit Board:\n\n(A) Quality measures;\n\n(B) Costs;\n\n(C) Health outcomes; and\n\n(D) Other information that is necessary for members of the public to evaluate\nthe value of health services delivered by each coordinated care organization\nand by each health benefit plan.\n\n(e) Establish evidence-based clinical standards and practice guidelines that\nmay be used by providers.\n\n(f) Approve and monitor community-centered health initiatives described in ORS\n413.032 ~~(1)(h)~~ _(1)(g)_ that are consistent with public health goals,\nstrategies, programs and performance standards adopted by the Oregon Health\nPolicy Board to improve the health of all Oregonians, and to regularly report\nto the Legislative Assembly on the accomplishments and needed changes to the\ninitiatives.\n\n(g) Establish cost containment mechanisms to reduce health care costs.\n\n(h) Ensure that Oregon's health care workforce is sufficient in numbers and\ntraining to meet the demand that will be created by the expansion in health\ncoverage, health care system transformations, an increasingly diverse\npopulation and an aging workforce.\n\n(i) Work with the Oregon congressional delegation to advance the adoption of\nchanges in federal law or policy to promote Oregon's comprehensive health\nreform plan.\n\n(j) Establish a health benefit package in accordance with ORS 741.340 to be\nused as the baseline for all health benefit plans offered through the health\ninsurance exchange.\n\n(k) Investigate and report annually to the Legislative Assembly on the\nfeasibility and advisability of future changes to the health insurance market\nin Oregon, including but not limited to the following:\n\n(A) A requirement for every resident to have health insurance coverage.\n\n(B) A payroll tax as a means to encourage employers to continue providing\nhealth insurance to their employees.\n\n(L) Meet cost-containment goals by structuring reimbursement rates to reward\ncomprehensive management of diseases, quality outcomes and the efficient use\nof resources by promoting costeffective procedures, services and programs\nincluding, without limitation, preventive health, dental and primary care\nservices, web-based office visits, telephone consultations and telemedicine\nconsultations.\n\n(m) Oversee the expenditure of moneys from the Health Care Provider Incentive\nFund to support grants to primary care providers and rural health\npractitioners, to increase the number of primary care educators and to support\nefforts to create and develop career ladder opportunities.\n\n(n) Work with the Public Health Benefit Purchasers Committee, administrators\nof the medical assistance program and the Department of Corrections to\nidentify uniform contracting standards for health benefit plans that achieve\nmaximum quality and cost outcomes and align the contracting standards for all\nstate programs to the greatest extent practicable.\n\n(o) Work with the Health Information Technology Oversight Council to foster\nhealth information technology systems and practices that promote the Oregon\nIntegrated and Coordinated Health Care Delivery System established by ORS\n414.570 and align health information technology systems and practices across\nthis state.\n\n(2) The Oregon Health Policy Board is authorized to:\n\n(a) Subject to the approval of the Governor, organize and reorganize the\nauthority as the board considers necessary to properly conduct the work of the\nauthority.\n\n(b) Submit directly to the Legislative Counsel, no later than October 1 of\neach even-numbered year, requests for measures necessary to provide statutory\nauthorization to carry out any of the board's duties or to implement any of\nthe board's recommendations. The measures may be filed prior to the beginning\nof the legislative session in accordance with the rules of the House of\nRepresentatives and the Senate.\n\n(3) If the board or the authority is unable to perform, in whole or in part,\nany of the duties described in ORS 413.006 to 413.042 and 741.340 without\nfederal approval, the authority is authorized to request, in accordance with\nORS 413.072, waivers or other approval necessary to perform those duties. The\nauthority shall implement any portions of those duties not requiring\nlegislative authority or federal approval, to the extent practicable.\n\n(4) The enumeration of duties, functions and powers in this section is not\nintended to be exclusive nor to limit the duties, functions and powers imposed\non the board by ORS 413.006 to 413.042 and 741.340 and by other statutes.\n\n(5) The board shall consult with the Department of Consumer and Business\nServices in completing the tasks set forth in subsection (1)(j) and (k)(A) of\nthis section.\n\n**_SECTION 13._ ** ORS 410.080 is amended to read:\n\n410.080. (1) The Department of Human Services is the designated single state\nagency for all federal programs under ORS 409.010 and 410.040 to 410.300\nexcept that the Oregon Health Authority is the single state agency responsible\nfor supervising the administration of all programs funded by Title XIX or\nTitle XXI of the Social Security Act as provided in ORS 413.032 ~~(1)(i)~~\n_(1)(h)_ .\n\n(2) Except as provided in ORS 410.070 (2)(d) and 410.100, the administration\nof services to clients under ORS 410.040 to 410.300 shall be through area\nagencies, and shall comply with all applicable federal regulations.\n\n**_SECTION 14._ ** _(1) Sections 2 to 4 of this 2025 Act and the amendments to\nORS 410.080, 413.011, 413.032, 414.312, 414.314, 414.318, 414.320, 414.334 and\n414.359 by sections 5 to 13 of this 2025 Act become operative on January 1,\n2026._\n\n_(2) The Oregon Department of Administrative Services may take any action\nbefore the operative date specified in subsection (1) of this section that is\nnecessary for the department to exercise, on and after the operative date\nspecified in subsection (1) of this section, all the duties, functions and\npowers conferred on the department by sections 2 to 4 of this 2025 Act and the\namendments to ORS 410.080, 413.011, 413.032, 414.312, 414.314, 414.318,\n414.320, 414.334 and 414.359 by sections 5 to 13 of this 2025 Act._\n\n**_SECTION 15._ ** _This 2025 Act takes effect on the 91st day after the date\non which the 2025 regular session of the Eighty-third Legislative Assembly\nadjourns sine die._\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": true
    }
  ]
}